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Abstract: Cancer cells interrelate with the bordering host microenvironment that encompasses
the extracellular matrix and a nontumour cellular component comprising fibroblasts and
immune-competent cells. The tumour microenvironment modulates cancer onset and progression, but
the molecular factors managing this interaction are not fully understood. Malignant transformation
of a benign tumour is among the first crucial events in colorectal carcinogenesis. The role of tumour
stroma fibroblasts is well-described in cancer, but less well-characterized in benign tumours. In the
current work we utilized fibroblasts isolated from tubulovillous adenoma, which has high risk for
malignant transformation, to study the interaction between benign tumour stroma and the circadian
clock machinery. We explored the role of the biological clock in this interplay taking advantage of an
experimental model, represented by the co-culture of colon cancer cells with normal fibroblasts or
tumour-associated fibroblasts, isolated from human colorectal tumour specimens. When co-cultured
with tumour-associated fibroblasts, colon cancer cells showed alterations in their circadian and
metabolic parameters, with decreased apoptosis, increased colon cancer cell viability, and increased
resistance to chemotherapeutic agents. In conclusion, the interactions among colon cancer cells and
tumour-associated fibroblasts affect the molecular clockwork and seem to aggravate malignant cell
phenotypes, suggesting a detrimental effect of this interplay on cancer dynamics.
Keywords: cancer; colorectal; tumour stroma; biological clock
1. Introduction
Colorectal cancer (CRC) ranks the fourth leading cause of cancer deaths and the third most
commonly diagnosed malignant neoplastic disease [1–3]. CRC develops gradually and initiates from
premalignant polyps such as tubular adenomas, tubulovillous adenomas, sessile serrated adenomas,
and traditional serrated adenomas [4]. Pre-neoplastic tissues of gastrointestinal cancers contain
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parenchymal transformed cells, as well as multiple host stromal cells [5]. Mounting evidence indicates
that tumour stroma, more than passively hosting and supporting the mutated epithelial cells, impacts
and/or even hastens colorectal carcinogenesis. The tumour microenvironment seems to play a crucial
role in CRC progression, metastasis, and drug resistance. It consists of an extracellular matrix,
tumour-associated fibroblasts (TAFs) able to uphold carcinogenesis and dwindle drug sensitivity,
activated immune cells, and tumour vasculature [6]. These components interrelate with the cancer
cells by means of a series of secreted molecules supporting paracrine signalling, as well as cell-to-cell
contact mechanisms, creating a bi-univocal communication array [7–10]. In particular, the signals
originating from CRC stromal cells take part in triggering specific gene expression signatures in
tumour parenchymal cells, which sequentially prompt deranged gene expression profiles in stromal
cells [11]. The tumour microenvironment changes during cancer progression in line with unremitting
modification of the signals originating from the different components of the microenvironment,
provoking altered responses from the adjacent cells. Moreover, colorectal tumorigenesis is supported
by alteration of essential cellular processes, such as cell cycle, proliferation and apoptosis, which are
hallmarked by periodic fluctuations. Rhythmicity of biological processes is driven at the cellular level
by molecular clockworks operated by transcriptional–translational feedback loops (TTFLs) [12,13]. In
mammals and humans, these TTFLs are mainly driven by the heterodimer complex formed by the
proteins BMAL1/ BMAL2 and CLOCK/NPAS2, which activate the transcription of PERIOD (PER1-3),
CRYPTOCHROME (CRY1-2), REV-ERB (REV-ERB1, REV-ERB2), and ROR (RORa, RORb, RORc) genes
and their corresponding proteins that fine-tune the transcriptional activity of BMAL1/2-CLOCK/NPAS2
heterodimers [14,15]. The biological clock drives crucial cellular processes, such as the cell division
cycle, metabolism, proliferation, DNA damage response, apoptosis, and autophagy, which when
altered are critical in cancer onset and progression [16–20]. Altered expression of PER genes was found
in non-small lung cancer patients [21], as well as in breast cancer patients. In the latter neoplastic
disease PER1-3 downregulation predicted poorer survival [22]. Cryptochrome proteins regulate cell
cycle progression, and their deficiency accelerates cancer cell proliferation [23], and enhances resistance
to chemotherapeutic agents [24]. Additionally, CLOCK gene upregulation predicts poorer outcome in
CRC patients, upholds colon cancer cell proliferation, and reduces apoptosis [25]. BMAL1 is necessary
for the p53-dependent stimulation of p21(Cip1/Waf1) [26] and BMAL1 deficiency hinders p53-dependent
cell cycle arrest triggered by DNA damage [27]. BMAL1 hinders the G2/M transition activating
WEE1 kinase expression, with successive inhibition of CDK1, and inhibits c-MYC reducing cyclin E
expression and cyclin E/Cdk2 activity, hampering the G1/S transition [28,29]. Severe alterations of the
biological clock functioning have been reported in the tumour tissue of CRC patients and in colon
cancer cells [30–37]. Thus, the aim of our study was to evaluate the putative impact of the interplay
between colon cancer cells and stromal cells on the function of the biological clock. To investigate this
hypothesis, we accessed the expression patterns of the core-clock genes, as well as the metabolic and
phenotypic characteristics of colon cancer cells upon interaction with stromal cells. We explored this
cross-talk using co-cultures of colon cancer cells (HCT116) and a commercial line of normal human
intestinal fibroblasts (HIFs), as well as primary normal fibroblasts (NFs) and primary tumour-associated
fibroblasts (TAFs) derived from specimens obtained from CRC patients. Our results bring forward
an important role of cell-to-cell communication in the regulation of the circadian phenotype, with
subsequent alterations in mitochondrial respiration, cellular apoptosis, and cytotoxicity.
2. Results
2.1. Co-Culture of Cell Lines with Different Clock Phenotypes Affects the Expression of Core-Clock Genes
A tumour is a complex tissue, which is composed of different cell types mainly derived from
the neighbouring stroma that constitute the tumour microenvironment. It is still unclear how the
individual molecular clocks of different cell types in a complex tissue may influence each other. We
therefore carried out co-culture experiments and evaluated the effect on the clock phenotype via
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bioluminescence measurements. In a first attempt, the colorectal cancer cell line HCT116 and the
human normal intestinal fibroblast cell line HIF were co-cultured. Colorectal cancer cell lines display
a variety of circadian phenotypes, which range from a completely disrupted clock to less dramatic
phenotypes, as shown in previous work [38]. For this study, we aimed at using a cell line with a robust
oscillator (well-defined circadian phenotype) to evaluate how such an oscillator may be affected by the
microenvironment, including primary tumour cells from patients. Since the HCT116 cell line represents
such a robust oscillator, as compared to other colorectal cancer cell lines, it was selected for this study
(Figure S1). Subsequently, we measured the clock phenotype in each cell type or in co-cultured cells,
but with only one cell type being transduced with a construct containing the BMAL1 promoter and
the luciferase coding sequence (BLH) (i.e., HIF-BLH cells or HCT116-BLH cells). In a second attempt,
HCT116 cells were co-cultured with NFs or TAFs. In this case, all cells were measured individually and
in co-culture, and we analysed the clock phenotype of HCT116 cells to evaluate whether co-culture
with stromal cells changed the oscillation profile. Under control conditions, HCT116 and HIF cells
showed significantly different periods (p < 0.05) (Figure 1A,D). Although the co-culture of both cell
lines did not lead to significant changes in period length or phase, the oscillatory patterns changed in
HIF-BLH cells upon co-culture with HCT116 cells (Figure 1D,E). In particular, the oscillations were
more robust when cells were measured in co-culture (Figure 1B). This effect could not be observed
when HCT116-BLH cells were measured in co-culture with HIF cells (Figure 1C–E).
Figure 1. Effect of co-culture on circadian rhythms in HCT116 and human intestinal fibroblast (HIF)
cells. Cells were lentivirally transduced and the human BMAL1-promoter (BLH) activity was measured
over five consecutive days. Cells were either co-cultured with the same cell line (A) or with a different
cell line (B,C). Shown is one representative replicate per condition. The BLH-cell line was measured.
Period (D) and phase (E) were calculated in samples with and without co-culture. Data are expressed
as mean ± SEM, n = 3. Significant changes (p < 0.05) between different conditions are marked with *.
To further explore the functioning of the circadian clock, we evaluated time-course measurements
of mRNA expression levels of a number of core-clock and clock-controlled genes in HCT116 and
HIF cells, both individually and in co-culture (Figure 2A,B). Samples were collected within a time
interval of 18 h. The first sample was collected 20 h after synchronization and the last sample 38
h after synchronisation. Most genes showed variations in their expression values over time in all
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three conditions with the exception of CLOCK in HIF cells and TIMELESS in HCT116 cells alone
and HCT116 in co-culture (Figure 2A). For nearly all genes, the expression in HIF cells reached its
lowest level at 32 h, while in the HCT116-HIF co-culture, the maximum was predominantly at 38 h
(Figure 2A,B). When comparing the expression patterns, the cluster of genes containing CLOCK, CRY1,
PER2, and PER3 showed a strongly different trend of regulation in HCT116-HIF co-culture conditions
in respect to HCT116 cells alone (Figure 2B). For most of these genes, this trend in regulation appeared
to be inverted (Figure 2A). Contrariwise, the expression pattern of other core-clock genes, such as
BMAL1, REV-ERBα, PER1, and TIMELESS, were similar in HCT116 cells and in the HCT116-HIF
co-culture, but they differed in HIF cells. Interestingly, the expression of RORA was severely damped
under co-culture conditions (Figure 2B). In addition to the changes observed in the bioluminescence
recordings experiments, these results suggest that the interplay between two cell types influences
the molecular clockwork at the gene expression level, likely to affect protein expression as well, as
observed for the oscillatory phenotype of the protein SIRT1 (Table S1 and Figure S2).
Figure 2. Co-culture of HCT116 and HIF cell lines alters the rhythmic expression of core-clock genes.
(A) Time-series expression profiles of core-clock genes and putative circadian-regulated genes in
HCT116 cells (dark blue), HIF cells (light blue), and a HCT116+HIF co-culture (pink). A sine–cosine









for the different conditions was chosen dependent on the period lengths observed in the long-term,
real-time bioluminescence recording of BMAL1 promoter activity. (B) Hierarchical clustering analysis
of sequential transcriptional changes of core-clock genes and clock-controlled genes. Colour code of
heatmaps is indicated.
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2.2. Co-Culture with Primary Fibroblasts Induces Circadian Changes in HCT116 Cells
Next, HCT116 cells were co-cultured with primary NFs or TAFs, and the effect on the circadian
phenotype was evaluated. We first determined the oscillatory profile, and the circadian parameters
period, and phase in single cell-type assay. The period of NFs and TAFs was significantly longer than
the period of HCT116 cells (Figure 3A,B) as observed also for the HIF cells (Figure 1). Furthermore,
the phase was significantly different in NFs and TAFs as compared to HCT116 cells (Figure 3C).
Interestingly, when HCT116-BLH were co-cultured with primary NFs and TAFs, we observed a
significantly longer period in HCT116 cells (Figure 3D,E) similar to the period observed for NFs and
TAFs. Lastly, we also observed a phase shift as compared to the normal HCT116 oscillatory profile
without co-culture (Figure 3F).
Figure 3. Cell-to-cell communication impacts the circadian phenotype. (A) HCT116, normal fibroblast
(NF), and tumour-associated fibroblast (TAF) cells were lentivirally transduced and theBMAL1-promoter
activity was measured over five consecutive days. Shown is one representative replicate per condition.
Period (B) and phase (C) were calculated. Data are expressed as mean ± SEM, n = 3. Significant changes
(p < 0.05) between different cells are marked with *. (D) HCT116, NF, and TAF cells were lentivirally
transduced and the BMAL1-promoter activity was measured over five consecutive days. HCT116
cells were either co-cultured with HCT116 cells or with NFs or TAFs. Shown is one representative
replicate per condition. The BLH-cells were measured. Period (E) and phase (F) were calculated. Data
are expressed as mean ± SEM, n = 3. Significant changes (p < 0.05) between different conditions are
marked with *.
Additionally, we carried out a new co-culture of the HCT116 cells with primary cells of a second
patient (with moderately differentiated colon adenocarcinoma) and also observed that, in this new
co-culture scenario, the cells from the cancer patient altered the clock phenotype of the HCT116. In
particular, there was a significant phase shift of 4.7 h as a result of the co-culture with NF and of 6.2 h
upon co-culture with TAF. Furthermore, the period of the oscillations showed alterations, although not
significant (Figure S3).
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Given that normal and tumour fibroblasts secrete soluble factors, which regulate a wide spectrum
of biological processes including proliferation, migration, differentiation, and apoptosis [5], we
wondered whether cytokines could play role in this intercellular communication. Of note, TNF-α (i.e.,
a multifunctional pro-inflammatory cytokine) is rhythmically encoded by TNF that is a clock-controlled
gene, and in turn alters the functioning of the biological clock [39]. We previously showed that TNF-α
and circadian gene modulation alters the expression of clock genes and triggers phenotypic changes
in lymphoma cells [40]. We therefore hypothesized that TNF-α could mediate some of the effects
observed in the oscillatory profile of HCT116 cells upon co-culture with fibroblasts. We evaluated the
responses of HIF and HCT116 to increasing doses of TNF-α and found interesting results: while no
change was observed in the circadian phenotype of HIF cells, HCT116 cells showed an increase in
period length and a phase shift (Figure 4 and Figure S4).
Figure 4. Effect of the stimulation with increasing amounts of human recombinant tumour necrosis
factor (TNF) on circadian rhythms in HCT116 cells. HCT116 lentivirally transduced cells were
cultured with increasing concentrations of human recombinant TNF (25, 50, and 100 ng/mL), and the
BMAL1-promoter activity was measured over five consecutive days (A). Shown is one representative
replicate per condition. Colour gradients represent the different concentrations of recombinant human
TNF used. Period (B) and phase (C) were calculated in the samples and comparisons were made to the
control condition. Data are expressed as mean ± SEM, n = 3. Significant changes (p < 0.05) between
different conditions are marked with *.
2.3. Circadian Changes Induced by Primary Fibroblasts Impact Metabolism, Proliferation, Viability,
Cytotoxicity, and Apoptosis in HCT116 Cells
Previous findings revealed that alterations in circadian rhythm and clock-regulated genes may
impinge on the metabolism of cancer cells, and that metabolic switching is a hallmark of an increased
aggressiveness [20]. Therefore, in a next step we tested whether the co-culture of colon cancer cells with
NFs and TAFs could also influence metabolic activity with impact on cell viability, cytotoxicity, and
apoptosis. Glycolysis, measured as the extracellular acidification rate (ECAR) reached by a given cell
after the addition of saturating amounts of glucose, was comparable in the three examined conditions
(HCT116 cells alone, HCT116 cells + NF, and HCT116 cells + TAF) (Figure 5A). The glycolytic capacity,
measured as the maximum ECAR reached by a cell following the addition of oligomycin, effectively
shutting down oxidative phosphorylation and driving the cell to use glycolysis to its maximum capacity,
was decreased in HCT116 cells and NF co-culture (Figure 5B). This condition was also characterized by
decreased glycolytic reserves, indicating the capability of a cell to respond to an energetic demand,
as well as how close the glycolytic function is to the cell’s theoretical maximum. Non-glycolytic
acidification, measuring other sources of extracellular acidification not attributable to glycolysis, was
decreased in both co-culture conditions (Figure 5C).
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Figure 5. Cell-to-cell communication impacts cell metabolism: glycolysis. (A) Glycolysis, (B) glycolytic
capacity, (C) nonglycolytic acidification, (D) glycolytic reserve, and (E) glycolytic reserve (%) in HCT116
cells cultivated alone or after co-culture with NFs or TAFs. Only HCT116 cells were measured. Data
are represented as mean ± SEM (n = 8). Significant changes (p < 0.05) between different conditions are
marked with *.
Co-culture with NFs or TAFs did not induce changes regarding the glycolytic activity in HCT116
cells (Figure 5A–E), whereas the mitochondrial activity was significantly altered (p < 0.05, Figure 6).
Basal respiration, a measure of oxygen consumption used to meet cellular ATP demand resulting from
mitochondrial proton leak and showing baseline cell energetic demand, and maximum respiration,
significantly increased after co-culture with NFs in HCT116 cells (Figure 6A,B). This condition was
also characterized by increased ATP production measuring the decrease in oxygen consumption
rate upon injection of the ATP synthase inhibitor oligomycin (Figure 6C). It represents the portion
of basal respiration used to drive ATP production and shows ATP produced by the mitochondria
that contributes to meeting the energetic needs of the cell. During co-culture of HCT116 and NF
cells, we also observed increased maximal respiration, measuring the maximal oxygen consumption
rate attained by adding the uncoupler FCCP, which mimics a physiological “energy demand” by
stimulating the respiratory chain to operate at maximum capacity, causing rapid oxidation of substrates
(sugars, fats, amino acids) to meet this metabolic challenge. Similarly, in this condition we observed
increased spare respiratory capacity, indicating the capability of the cell to respond to an energetic
demand, as well as how close the cell is to respiring to its theoretical maximum. The ability of the cell
to respond to energetic demands can be an indicator of cell fitness or flexibility, as well as increased
non-mitochondrial respiration (oxygen consumption that persists due to a subset of cellular enzymes
that continue to consume oxygen after rotenone and antimycin-A addition). This is important for
obtaining an accurate measure of mitochondrial respiration. Proton (H+) leak, indicating the remaining
basal respiration not coupled to ATP production and an indicator of mitochondrial damage or of
a mechanism to regulate the mitochondrial ATP production, was greatly increased when HCT116
cells where co-cultured with TAF (Figure 6D). On the other hand, co-culture with TAFs tendentially
decreased the mitochondrial activity (Figure 6A–H). Co-culture with NFs induced a more energetic
phenotype in HCT116 cells, while the energy phenotype after co-culture with TAFs was only slightly
changed (Figure S5).
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Figure 6. Cell-to-cell communication impacts cell metabolism: mitochondrion. (A) Basal respiration,
(B) maximum respiration, (C) ATP production, (D) proton leak, (E) non-mitochondrial respiration,
(F) coupling efficiency (%), (G) spare respiratory capacity, and (H) spare respiratory capacity (%) in
HCT116 cells cultivated alone or after co-culture with NF or TAF. HCT116 cells were measured. Data
are represented as mean ± SEM (n = 8). Significant changes (p < 0.05) between different conditions are
marked with *.
Since circadian changes and TAFs are both known to influence cell viability, apoptosis, and
resistance to cytotoxic agents of cancer cells, we therefore investigated the functional implications
of this co-culture scenario regarding cytotoxicity, viability, and apoptosis. We measured live-cell
protease activity using a fluorogenic, cell-permeant peptide substrate; dead-cell protease activity using
a cell-impermeant, fluorogenic peptide substrate; and caspase-3/7 activation as a key indicator of
apoptosis. The co-culture of HCT116 cells with TAF lead to an increase of cancer cell viability and
resistance to cytotoxic agents, whereas apoptosis significantly decreased. Notably, the co-culture with
NF also increased resistance to cytotoxic agents and decreased apoptosis (Figure 7).
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Figure 7. Cell-to-cell communication impacts cancer cell phenotype. (A) Viability, (B) cytotoxicity, and
(C) apoptosis in HCT116 cells cultivated alone or after co-culture with NF or TAF. Only HCT116 cells
were measured. Data are represented as mean ± SEM (n = 5). Statistically significant values (p < 0.05)
are indicated with *. (D) The interaction of cancer cells (top left) with stromal cells (middle left) impacts
their circadian phenotype, determines transcriptome modifications, and governs metabolic re-wiring
to influence the response to chemotherapy.
Taken together the results attained from our work showed that cell-to-cell communication of
primary fibroblasts and HCT116 cells influenced the circadian phenotype, changed mitochondrial
respiration, prevented cells from apoptosis, and increased resistance to cytotoxic agents.
3. Discussion
Currently, it is common in oncological research to carry out experiments in human cancer cell
lines representing only one type of tumour cell. However, a tumour is a complex tissue composed
of different cell types mainly derived by the neighbouring stroma, which constitute the tumour
microenvironment [32]. Colorectal cancer tissue contains parenchymal tumour cells and host stromal
cells. Tumour stroma acts as an essential modulator and/or even a driver of tumorigenesis, in addition
to its role as a supportive structure harbouring neoplastic cells. Among various cell types, including
endothelial and immune cells, stromal cells also comprise fibroblasts that may transform into TAFs able
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to support tumorigenesis and impair drug sensitivity. Interactions between these different cell types
influence tumourigenesis [32]. In normal colonic mucosa, the stromal population mainly consists of
fibroblasts [41]. During tumourigenesis, through different pathways, fibroblasts may differentiate into
TAFs, which become the main cellular component of tumour stroma [42]. TAFs secrete growth factors
and thereby support tumour growth and migration. They promote survival and proliferation in primary
tumours, as well as in metastasis [43]. Given the known importance of the tumour microenvironment
and its constituents, TAFs might be particularly relevant as diagnostic and prognostic biomarkers and
should be considered as potential targets for anticancer therapy. It is important to notice that stroma
cells, as used in our study, are different from stem cells, and even though the role of stem cells in
malignancy is an extremely interesting topic, it is out of the focus of the current study. A recent work by
Matsunaga and colleagues [44] addresses the relevance of the molecular clock in the microenvironment
for cancer development in a mouse model, and their work shows that cells with a properly ticking
biological clock that populate the tumor microenvironment could rhythmically and spontaneously
regulate clock-silenced breast cancer stem cells through the circadian release of diffusible factors (i.e.,
WNT signaling components). The authors further demonstrate that an optimized dosing schedule
based on circadian dynamics of mouse breast cancer stem cells improves the antitumor effects of
the drug [44]. Cancer stem cells (CSCs), also known as tumour-initiating cells (TICs), are cancer
cells that possess capabilities of proliferation, differentiation, and self-renewal (i.e., CSCs are more
aggressive cancer cells and are different from normal tissue adult stem cells, such as mesenchymal
stem cells). Cancer stroma contains mesenchymal stem cells (MSCs) that can function as an origin
of myofibroblasts, also known as cancer-associated fibroblasts (CAFs), which then support cancer
progression [45,46]. MSCs present in the tumour stroma, and when damaged (e.g., by cellular stress),
can form a direct contact with cancer cells and serve as a source of nutrients that then significantly
increases cancer cell growth capacity, metastasis ability, and resistance to cancer drugs.
Cell-to-Cell Communication Impacts on the Circadian Phenotype
Bidirectional interactions among stromal and parenchymal cancer cells operated by secreted
signalling molecules turn on specific gene expression signatures and set up network circuits hardwiring
the tumour microenvironment [32]. Long-term, real-time bioluminescence recording performed in
various colon cancer cell lines showed different profiles with increasing pattern derangements in cell
lines with increasingly malignant phenotypes [38].
Based on this knowledge, we evaluated the impact of cell-to-cell communication on the circadian
phenotype of HCT116 colon cancer cells upon co-culture with normal and tumour fibroblasts. In our
study, oscillatory patterns rendered by long-term, real-time bioluminescence recordings suggested
different functioning of the biological clock in the examined colon cancer cells (HCT116 cell line) as
well as in normal and tumour fibroblasts. Co-culture induced both a phase shift and a longer period
in HCT116 cells. Interestingly, the longer period of HCT116 cells after co-culture closely resembled
the period length of NFs and TAFs, suggesting that fibroblasts influenced the period length in this
cancer cell line into the direction of their own period length. Neoplastic cells and bordering stromal
cells in the tumour microenvironment interact either through direct contact or by means of chemokine
and cytokine signalling that impacts cancer cell phenotype (survival, apoptosis, response to cytotoxic
agents), as well as neoplastic disease outcome (eradication or progression). We challenged our in vitro
model with TNF-α, and the results obtained suggest a direct impact on the functioning of the biological
clock and presumably on cellular processes regulated by the molecular clockwork. It would be
interesting to investigate, in future work, if the NFs or the TAFs effectively secrete TNF-α or other
cytokines, which may be involved in cell-to-cell communication and may alter the circadian phenotype
of the surrounding cells. In particular, TNF-α treatment induced a longer period and a phase shift
of HCT116 cells, which suggested a potential path via which fibroblasts can impact circadian clock
functioning in HCT116 cells. The different patterns of bioluminescence oscillations were paralleled
by different patterns of expression of core-clock genes (BMAL1, CLOCK, CRY1-2, and PER1-3) and
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clock-controlled genes (WEE1, cMYC) assessed in time-course gene expression experiments at the
mRNA level in the examined cell types when evaluated alone and in co-culture. The results are in
line with existing findings that co-culture of fibroblasts and other cells has a profound impact on the
expression of circadian genes [6]. The observed effects on the circadian phenotype could be extended
to the metabolic activity, cytotoxicity, and apoptosis. The co-culture of HCT116 cells with primary NF
and TAF triggered important metabolic changes, improved colon cancer cell viability, and reduced
response to chemical agents. While glycolysis was not affected in HCT116 cells upon co-culture,
mitochondrial activity was altered. Basal respiration, maximum respiration, and ATP production
were significantly increased after co-culture with NFs in HCT116 cells. On the other hand, co-culture
with TAFs decreased the mitochondrial activity. These results suggest that the surrounding stroma
regulates metabolic activity in cancer cells, and the effects on cell metabolism may differ based on the
type of surrounding cells. Furthermore, cytotoxicity and apoptosis were both significantly decreased
in HCT116 cells when co-cultured with NFs or TAFs, pointing to a putative role of the surrounding
stroma in protecting cancer cells from cell death and promoting cell survival and growth. It is relevant
to point out that in this study we discuss the effect of TAFs prior to, or at the moment of, malignant
transformation. Neoplastic polyps, including tubular adenomas, villous adenomas, and tubulovillous
adenomas, are precursors of colon cancers. In particular, patients with tubulovillous adenomas are
at very high risk to acquire malignant lesions. This hints that epithelial cells in these adenomas can
frequently undergo malignant transformation. Neither the role of TAFs in this transformation nor the
effect of TAFs on epithelial cells that are about to, or have just undergone malignant transformation
are known.
The insights gained from the co-culture experiments show that cancer cells are highly affected by
surrounding cells not only with respect to their circadian phenotype, but also with respect to their
metabolic activity and cell survival. Our results hint to a modification in the regulation of the molecular
clockwork functioning triggered by an interplay between neoplastic and tumour-derived stromal cells,
which can ultimately modify colon cancer cell phenotypes.
4. Materials and Methods
4.1. Cell Culture
CaCo2, HCT116, HT29, LIM1215, RKO, SW480, and SW620 cells were maintained in DMEM
low-glucose culture medium (Lonza, Basel, Switzerland supplemented with 10% FBS (Life Technologies,
Thermo Fisher Scientific, Waltham, MA, USA), 1% penicillin–streptomycin (Life Technologies),
2 mM Ultraglutamine (Lonza), and 1% HEPES (Life Technologies). Normal colon fibroblasts and
tubulousvillous adenoma-associated fibroblasts (TAFs) were derived from the same patient. TAFs
were isolated from an ulcerated and bleeding neoformation that was diagnosed as tubulovillous
adenoma with low-grade dysplasia and reactive hyperplasia in the local lymph nodes. Normal
colon counterpart fibroblasts were isolated at a distance of 20 cm from the adenoma. Samples were
collected from two patients using the same procedure (the samples from one patient, described above,
are referred as NF and TAF, and from the other patient, diagnosed with moderately differentiated
colon adenocarcinoma, as NF2 and TAF2). Human normal colon intestinal primary fibroblasts
(HIFs) were purchased from Cliniscience (Cliniscience, Nanterre, France). HIF cells and normal
and tumour-associated fibroblasts were maintained in MEM-α (Gibco, Thermo Fisher Scientific,
Waltham, MA, USA) medium supplemented with Hyclone FBS (GE healthcare, Munich, Germany), 1×
antibiotic–antimycotic (Gibco), and 1×MEM nonessential amino acids solution (Gibco). The ethical
permission for the study was approved by IRCCS (Istituto di Ricerca a Carattere Clinico e Scientifico)
SDN (Comitato Etico per la Sperimentazione Clinica Progetto N:ro 2013-01-02) and Monaldi Hospital
ethical committees (Deliberazione del Direttore Generale n:o 1239).
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4.2. Lentivirus Production
Lentiviral elements containing a BMAL1-promoter-driven luciferase (BLH) were generated as
briefly described: HEK293T cells were seeded in 175 cm2 culture flasks and co-transfected with
12.5 µg packaging plasmid psPAX, 7.5 µg envelope plasmid pMD2G, and 17.5 µg BMAL1-promoter
(BLH)-luciferase expression plasmid using the CalPhos mammalian transfection kit (Clontech, Mountain
View, CA, USA) according to the manufacturer’s instructions. To harvest the lentiviral particles, the
supernatant was centrifuged at 4100× g for 15 min to remove cell debris and passed through a 45 µm
filter. The lentiviral particles were stored at −80 ◦C.
4.3. Transduction with Lentiviral Vectors
For lentiviral transduction, cells (i.e., HCT116, HIF, primary NF, and TAF) were seeded in 6-well
plates. On the day of transduction, 1 mL medium and 1 mL of lentiviral particles was added. A total
of 8 µg/mL protamine sulfate (Sigma-Aldrich, St. Louis, MO, USA) and 4 µg/mL polybrene (Sigma)
was used to enhance transduction efficiency. The next day, the medium was replaced, and selection
medium was added one day later (complete growth medium containing 100 µg/mL hygromycin B)
(Gibco) to obtain stable transduced cells and incubated at 37 ◦C with 5% CO2 atmosphere.
4.4. Cell Culture for Bioluminescence Measurements
Stable-transduced cell populations were selected and maintained in medium containing
hygromycin B (100 µg/mL, Gibco). For live-cell bioluminescence recording, cells were maintained in
phenol red-free DMEM (Gibco) containing 10% FBS (Life Technologies), 1% penicillin–streptomycin
(Life Technologies), and 250 µM D-Luciferin (PJK, Kleinblittersdorf, Germany). HIF cells and normal
and tumour-associated fibroblasts were maintained in phenol red-free MEM-α (Gibco) medium
supplemented with 10% Hyclone FBS (GE healthcare), 1× antibiotic–antimycotic (Gibco), and 1×
MEM nonessential amino acids solution (Gibco). Cell morphology and density were controlled by
light microscopy. All cells were incubated at 37 ◦C in a humidified atmosphere with 5% CO2. Cells
were synchronised by medium change prior to measurement. Bmal1-promoter-(BLH)-reporter activity
was measured using a LumiCycle instrument (Actimetrics, Wilmette, IL, USA) for five consecutive
days. Bioluminescence data were analysed using the Chronostar software (version 3.0, no commercial
software) [47].
4.5. Co-Culture, Synchronization, and Bioluminescence Measurements of Circadian Rhythms
One day prior to the start of the co-culture, cells were seeded at the appropriate density,
dependent on the cells used. Un-transduced cells were seeded in 35 mm dishes, and transduced cells
(BMAL1-promoter-(BLH)-reporter) were seeded on 22 mm coverslips. The next day, cells on coverslips
were added to the appropriate un-transduced cells. From this timepoint on, all cells were maintained
in MEM-αmedium. Co-culture was maintained for 48 h. For long-term, real-time bioluminescence
recording, cells were synchronized by serum shock with medium containing 50% FBS for 2 h. Next, cells
were washed once with 1× PBS (Life technologies), and phenol red-free MEM-α (Gibco) supplemented
with 250 µM D-Luciferin (PJK) was added. BMAL1-promoter-(BLH)-reporter activity was measured,
using a LumiCycle instrument (Actimetrics) for 5 d. Raw bioluminescence time-series data were
detrended with a moving average method, the 24 h running average, using the ChronoStar analysis
software [47].
4.6. RNA Extraction and First-Strand cDNA Synthesis
Total RNA was extracted with TRIzol reagent (Invitrogen, Thermo Fisher Scientific, Karlsruhe,
Germany) from HCT116 and HIF cells. The amount of total RNA was determined by UV
spectrophotometry using the Nano Drop Spectrophotometer (Nanodrop Technology, Thermo Fisher
Scientific, Waltham, MA, USA), and RNA integrity was assessed by the Agilent 2100 Bioanalyzer
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(Agilent Technologies, Santa Clara, CA, USA) after digestion by DNaseI. Next, 1.0 µg of total RNA
was reversed transcribed using the High-Capacity cDNA Archive Kit following the manufacturer’s
instructions (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA).
4.7. Quantitative Real-Time Reverse Transcription PCR Assay
To assess the differential expression of the core-clock genes and clock-controlled genes in HCT116
and HIF cells assessed alone and HCT116 cells in co-culture, quantitative real-time PCR (q-PCR) assay
was performed by using BMAL1 (ARNTL, QT00011844), BMAL2 (ARNTL2, QT00068250), CLOCK
(QT00054481), CRY1 (QT00025067), CRY2 (QT00094920), CSNK1E (QT00999152), REV-ERBα (NR1D1,
QT00000413), PER1 (QT00069265), PER2 (QT00097713), PER3 (QT00011207), RORA (QT00072380),
SIRT1 (QT00051261), TIMELESS (QT00019789), TIPIN (QT00054334), WEE (QT00038199), and c-MYC
(QT00035406) Human QuantiTec Primers Assay (SYBR Green QuantiTect Primers Assay; QIAGEN,
Hilden, Germany). All qPCRs were performed in a 25 µL final volume, with three replicates per
sample, by using QuantiFast SYBR Green PCR kit (QIAGEN) and ran in an ABI PRISM® 7700 Sequence
Detection System (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA). The data were
analysed using the default and variable parameters available in the SDS software package (version 1.9.1;
Applied Biosystems). The housekeeping gene GAPDH was used as control to normalize the target gene
expression levels. The log2 fold change in expression compared to the expression at time point 20 h was
calculated with the 2−∆∆CT method. Two biological replicates were each assayed in triplicate, and results
were expressed as mean ± standard deviation (SD). Hierarchical clustering analysis was performed on
qPCR data normalized as previously described [48]. The constant reference (K) for data normalization
was obtained by averaging the Cq of GAPDH across all samples (K = 14.67). Clustering analysis was
performed on Cq-normalized and median-centred settings, using uncentered correlation and centroid
linkage (Cluster 3.0 for Mac OS X; http://bonsai.hgc.jp/~{}mdehoon/software/cluster/software.htm),
and visualized by Java TreeView (http://jtreeview.sourceforge.net).
4.8. Western Blotting
For protein isolation, cells were gently detached from the dish, sedimented by low-speed
centrifugation, and resuspended in lysis buffer. Aliquots containing 30 µg of proteins from each
cell lysate were used for SDS polyacrylamide gel electrophoresis and transferred to a nitrocellulose
membrane (GE Healthcare) using the Trans-Blot Turbo Transfer System (Bio-Rad, Hercules, CA, USA).
Membranes were probed with the following primary antibodies: SIRT1 (H-300) (1:1000) (120 kDa)
Santa Cruz sc-15404 and GAPDH (1:2500; Abcam ab9485, Cambridge, UK). After incubation with the
corresponding suited horseradish peroxidase-conjugated secondary antibody (1:2000; Abcam ab205718),
signals were developed using the enhanced chemiluminescence kit (ECL™ Prime Western Blotting
System, GE Healthcare), acquired by ChemiDoc Imaging System XRS+ (Bio-Rad), and analysed for
densitometry with the ImageJ software (version 2.0, National Institutes of Health, Bethesda, MD, USA).
4.9. Measurements of Cellular Response to TNF-α Challenge
Two days before bioluminescence measurements, 1–5 × 105 HIF and HCT116 cells, previously
transduced with BLH, were seeded in 35 mm dishes. The synchronization was carried out by medium
change: cells were washed with 1× PBS (Life technologies) and 2 mL of phenol red-free DMEM (Gibco)
containing 10% FBS (Life Technologies), 1% penicillin–streptomycin (Life Technologies), and 250 µM
D-Luciferin (PJK) was added. Cells were stimulated by the addition of increasing concentrations of
recombinant human TNF-α (Biolegend, San Diego, CA, USA), 25, 50, and 100 ng/mL, to the medium.
4.10. Glycolytic Function
Glycolytic activity was determined using a Seahorse XFe96 Analyzer (Agilent, Santa Clara, CA,
USA) and the Seahorse XF Glycolysis Stress Test Kit (Agilent). Cells were seeded one day prior
to the assay in 96-well seahorse plates. The assay was performed according to the manufacturer’s
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instructions. For the glycolysis stress test, seahorse XF base medium (Agilent) supplemented with 2 mM
L-glutamine (Thermo Fisher scientific, Waltham, MA, USA) was used, and 10 mM glucose (Agilent),
1 µM oligomycin (Agilent) and 50 mM 2-DG (Agilent) were used for the injections. Subsequently,
plates were normalised based on the DNA content using the CyQuant kit (Thermo Fisher scientific)
according to the manufacturer’s instructions. Data were analysed using the wave software (Agilent).
4.11. Mitochondrial Function
Mitochondrial respiration was determined using a Seahorse XFe96 Analyzer (Agilent) and the
Seahorse XF Cell Mito Stress Test Kit (Agilent). Cells were seeded one day prior to the assay in
96-well seahorse plates. The assay was performed according to the manufacturer’s instructions. For
the cell mito stress test, seahorse XF base medium (Agilent) supplemented with 2 mM L-glutamine
(Thermo Fisher scientific), 5.5 mM glucose (Agilent), and 1 mM sodium pyruvate was used, and 2 µM
oligomycin (Agilent), 0.5 µM FCCP (Agilent), and 0.5 µM rotenone/antimycin A (Agilent) were used
for the injections. Subsequently, plates were normalised based on the DNA content using the CyQuant
kit (Thermo Fisher scientific) according to the manufacturer’s instructions. Data were analysed using
the wave software (Agilent, Santa Clara, CA, USA).
4.12. Measurement of Cell Viability, Cytotoxicity, and Apoptosis
To determine cell viability, cytotoxicity, and apoptosis, the ApoTox-Glo Triplex Assay (Promega,
Madison, WI, USA) was used. Cells were seeded in black 96-well half-area plates with clear bottoms.
The assay was performed according to the manufacturer’s instructions. Subsequently, plates were
normalised based on the DNA content using the CyQuant kit (Thermo Fisher scientific) according to
the manufacturer’s instructions.
4.13. Statistical Analysis
Statistical analysis was conducted with the programming language and software environment for
statistical computing and graphics in R. Rhythmic variation was tested by fitting the model










to time-series gene and protein expression values using the R package HarmonicRegression [49].
Period ω for the different conditions was chosen dependent on the period lengths observed in the
long-term, real-time bioluminescence recording of BMAL1 promoter activity (HCT116: 20 h, HIF: 25 h,
and HCT116+HIF: 22 h).
Co-culture experiments were carried out with at least three biological replicates for each condition.
All results are represented as mean ± SEM. Statistical analysis of the results was performed using
one-way ANOVA followed by Tukey’s multiple comparisons test. A p-value < 0.05 was considered
statistically significant (* p < 0.05; ** p < 0.01; and *** p < 0.001).
5. Conclusions
Taken together, the results from this study suggest that the interplay of colon cancer cells with
tumour-associated stromal cells, in particular TAFs, impacts the molecular clockwork with subsequent
alteration of metabolic parameters, improvement of colon cancer cell viability, and decrease of apoptotic
response to chemical agents. This can ultimately enhance the malignant phenotype of colon cancer
cells and represents a potential target for therapeutic intervention.
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